Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
The emergence of new immunosuppressants, such as the macrolide drug tacrolimus (prograf), has recently become one of the most important advances in transplantology. Tacrolimus belongs to calcineurin inhibitors and differs from cyclosporine in a rapider and uniform bile acid-independent absorption, c...
Main Authors: | O. N. Rzhevskaya, A. V. Pinchuk, R. V. Storozhev, I. V. Dmitriev |
---|---|
Format: | Article |
Language: | English |
Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-08-01
|
Series: | Трансплантология (Москва) |
Subjects: | |
Online Access: | https://www.jtransplantologiya.ru/jour/article/view/255 |
Similar Items
-
Tacrolimus for the Treatment of Ulcerative Colitis
by: Katsuyoshi Matsuoka, et al.
Published: (2015-07-01) -
Evaluation of the Efficacy of Topical Tacrolimus and Intraperitoneal Cyclosporine as a Treatment Method for Acute Rejection In vivo Model of Skin Allotransplantation
by: Dilgam Mammadov, et al.
Published: (2025-01-01) -
CORNEAL GRAFT REJECTION AFTER KERATOPLASTY
by: S. V. Trufanov, et al.
Published: (2017-10-01) -
Immunosuppression with prolonged-release tacrolimus in kidney or liver transplantation in India
by: Dinesh Khullar, et al.
Published: (2017-01-01) -
FIRST EXPERIENCE IN SYSTEMIC ADMINISTRATION OF EVEROLIMUS IN RENAL TRANSPLANTATION FROM EXPANDED CRITERIA DONORS IN RUSSIAN FEDERATION
by: I. V. Uliyankina, et al.
Published: (2017-01-01)